Immunocore Holdings (IMCR) Accounts Payables: 2022-2025
Historic Accounts Payables for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $23.0 million.
- Immunocore Holdings' Accounts Payables rose 16.40% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 16.40%. This contributed to the annual value of $25.1 million for FY2024, which is 41.03% up from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' Accounts Payables is $23.0 million, which was down 3.77% from $23.9 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Accounts Payables peaked at $29.1 million during Q1 2025, and registered a low of $14.4 million during Q4 2022.
- Its 3-year average for Accounts Payables is $21.7 million, with a median of $21.5 million in 2024.
- Data for Immunocore Holdings' Accounts Payables shows a peak YoY skyrocketed of 87.76% (in 2025) over the last 5 years.
- Over the past 4 years, Immunocore Holdings' Accounts Payables (Quarterly) stood at $14.4 million in 2022, then rose by 23.17% to $17.8 million in 2023, then surged by 41.03% to $25.1 million in 2024, then grew by 16.40% to $23.0 million in 2025.
- Its last three reported values are $23.0 million in Q3 2025, $23.9 million for Q2 2025, and $29.1 million during Q1 2025.